When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
What’s Happening: Savara, last month, reported a Q2 loss of $0.07 per share.
What Savara Does: Savara is a pharmaceutical company. The company develops novel therapies for the treatment of serious or life-threatening rare respiratory diseases.
22nd Century Group
What’s Happening: 22nd Century Group recently said it will enter the specialty hops market.
What 22nd Century Group Does: 22nd Century Group is a US-based plant biotechnology company. It focuses on developing technology that allows the increase or decrease in the level of nicotine and other nicotinic alkaloids in tobacco plants and levels of cannabinoids in cannabis plants through genetic engineering and plant breeding.
What’s Happening: Vyant Bio and Cyclica, in August, reported a strategic collaboration to identify compounds to treat CDKL5 deficiency disorder.
What Vyant Bio Does: Vyant Bio Inc is emerging as an advanced biotechnology drug discovery company.
See more from Benzinga
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.